<a href=https://pubmed.ncbi.nlm.nih.gov/22228887/>Zoya Demidenko</a>: Scientist in Cancer Studies
<a href=https://www.benthamdirect.com/content/journals/cpd/22/16>Zoya Demidenko</a> is a notable investigator affiliated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, building a strong background in biomedical investigation.
Her scholarly contributions encompasses multiple key fields, including the PI3K/AKT/mTOR molecular pathway, cellular cycle control, cell senescence, and cancer science. As of now, she has co-authored more than 46 scientific papers, which have received over 4,100 citations — a indicator to the significance of her research.
One of her most notable contributions concerns explaining the processes of cellular senescence. Her research showed that when the cell cycle is blocked yet cellular expansion persists, cells enter senescence. Significantly, <a href=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=>Zoya Demidenko</a> demonstrated that this shift is inhibited by medication using substances such as rapamycin.
<a href=https://www.pinterest.com/zoyademidenko/>Zoya Demidenko</a> has additionally contributed greatly to cancer treatment investigation, especially in the domain of selective cell protection — a method aimed at safeguarding healthy cells from anticancer drugs whilst leaving cancer cells susceptible. This approach carries considerable hope for reducing the side effects of oncological therapy.
Throughout her professional journey, Demidenko has partnered with prominent researchers globally, among them Dr. Mikhail Blagosklonny. Her publications is published in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, <a href=https://www.instagram.com/zoyamonros/>Zoya Demidenko</a> is recognized as a widely cited contributor in current cancer research, whose results keep to shape our understanding of the way cells age, respond to therapy, and how cancer may be more successfully combated.
uk.linkedin.com/in/berezutskayahttps://w...rk-ny/de6fqfq45eme2/
